美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,229.17

-22.0642-1.76%

漲家數：3

跌家數：4

平家數：- -

市盈率：- -

高：1,257.62

開：1,252.13

低：1,216.60

收：1,251.24

資料載入中...

【沃森生物：20價肺炎球菌多糖結合疫苗獲臨牀試驗批准】沃森生物公告，公司及子公司共同申請的20價肺炎球菌多糖結合疫苗獲得國家藥品監督管理局簽發的《藥物臨牀試驗批准通知書》，通知書編號為2025LP01099。該疫苗是在已上市產品13價肺炎球菌多糖結合疫苗基礎上開發的迭代升級產品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共計7種血清型，用於預防由本品所含20種肺炎球菌血清型引起的感染性疾病。全球已上市20價肺炎球菌多糖結合疫苗的廠家僅有美國輝瑞公司一家，國內尚未有20價肺炎球菌多糖結合疫苗上市銷售。

GLP-1減肥藥市場博弈：禮來領航突破、輝瑞折戟沉沙，創新戰如何取勝？

21世纪经济报道

輝瑞4月17日成交額為12.06億美元

諾和諾德4月17日成交額為18.73億美元

【減肥藥概念盤初活躍金凱生科漲超10%】減肥藥概念盤初活躍，金凱生科漲超10%，昊帆生物、華東醫藥、翰宇藥業、百花醫藥、一品紅、常山藥業等跟漲。消息面上，禮來口服減肥藥Orforglipron三期臨牀數據亮眼，股價漲逾14%。

諾和諾德盤初跌8%

每日经济新闻

碩迪生物盤中異動早盤急速上漲19.86%報22.21美元

盤前 | 禮來漲超11%，聯合健康重挫19%；霸王茶姬今日上市，IPO定價28美元

老虎资讯综合

蒙特利爾銀行：將輝瑞（PFE.N）目標價從36美元下調至30美元。

禮來(LLY.N)盤前大漲13%，此前其發佈了減肥藥研究數據。

輝瑞4月16日成交額為8.36億美元

諾和諾德4月16日成交額為4.00億美元

禮來4月16日成交額為24.37億美元

輝瑞：CDC建議將呼吸道合胞病毒疫苗擴大到年輕人。

【歐股“十一羅漢”收盤播報｜阿斯麥收跌約5.2%，諾和諾德跌超1%】週三，阿斯麥控股荷蘭阿姆斯特丹股價收跌5.19%，報574.00歐元。諾和諾德哥本哈根股價收跌1.03%，報421.30。賽諾菲跌1.34%，LVMH集團、歐萊雅、羅氏製藥、阿斯利康、德國思愛普Sap、葛蘭素史克跌0.71%-0.04%，諾華和雀巢分別漲0.29%和0.49%。此外，半導體概念股普遍收跌，除阿斯麥控股之外，BE半導體實業和ASM國際至多跌3.2%，Soitec、德國愛思強、意法半導體跌1.85%-1.31%，英飛凌也跌0.96%。

碩迪生物盤中異動股價大跌5.03%

因受試者出現肝損傷項目終止輝瑞減肥藥研發再遇挫

禮來(LLY.US)米吉珠單抗注射液新適應症上市申請獲CDE受理

智通财经网

輝瑞、禮來新適應症在華報產！康弘Trop2-ADC嶄露頭角

医药经济报

文件顯示，沃爾瑪與欽奈辦事處達成交易，提升在印度的科技影響力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1229.1708,"timestamp":1745265599999,"preClose":1251.235,"halted":0,"volume":57826241,"delay":0,"changeRate":-0.017634,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-22.064209,"latestTime":"04-21 16:00:00 EDT","open":1252.1276,"high":1257.6151,"low":1216.6044,"amount":4848730365.862926,"amplitude":0.032776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.286466,"peRate":32.45662,"turnoverRate":0.005474,"increases":3,"decrements":4,"flats":0,"marketCap":1310903118528,"floatMarketCap":1235170757472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1257.6151,"amplitude":0.032776,"preClose":1251.235,"low":1216.6044,"pbRate":"9.286466","latestPrice":1229.1708,"volume":57826241,"delay":0,"open":1252.1276,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1177.7317,"twentyDayClose":1358.6935,"sixtyDayClose":1290.7499,"secType":"PLATE","market":"US","turnoverRate":0.005474,"peRate":32.45662,"marketCap":1310903118528,"floatMarketCap":1235170757472,"timestamp":1745265599999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":3,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528681880","title":"【沃森生物：20價肺炎球菌多糖結合疫苗獲臨牀試驗批准】沃森生物公告，公司及子公司共同申請的20價肺炎球菌多糖結合疫苗獲得國家藥品監督管理局簽發的《藥物臨牀試驗批准通知書》，通知書編號為2025LP01099。該疫苗是在已上市產品13價肺炎球菌多糖結合疫苗基礎上開發的迭代升級產品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共計7種血清型，用於預防由本品所含20種肺炎球菌血清型引起的感染性疾病。全球已上市20價肺炎球菌多糖結合疫苗的廠家僅有美國輝瑞公司一家，國內尚未有20價肺炎球菌多糖結合疫苗上市銷售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528681880","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528681880?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 19:21","pubTimestamp":1744975312,"startTime":"0","endTime":"0","summary":"沃森生物公告，公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》，通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型，用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家，国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18192149669574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","300142","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","BK1141","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","159646","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","BK0239","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","BK1576","BK0077","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","03347","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","BK0070","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2528398720","title":"GLP-1減肥藥市場博弈：禮來領航突破、輝瑞折戟沉沙，創新戰如何取勝？","url":"https://stock-news.laohu8.com/highlight/detail?id=2528398720","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528398720?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 15:37","pubTimestamp":1744961820,"startTime":"0","endTime":"0","summary":"全球GLP-1减肥药市场正迎来新一轮格局重塑。礼来在GLP-1赛道实现突破性进展之际，辉瑞却因安全性问题终止了口服GLP-1药物Danuglipron的研发，这也标志着其在该赛道的再次失利。在安全性方面，ACHIEVE-1研究中，orforglipron的整体安全性与GLP-1类药物一致。在礼来有效性、安全性均获得较好反响的同时，辉瑞安全性问题致口服赛道折戟。这是辉瑞在GLP-1减重药上的再次折戟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041815395094d9c96c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041815395094d9c96c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0122379950.USD","LU2106854487.HKD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU0820561818.USD","LLY","GLP","SG9999015945.SGD","LU2237443622.USD","BK4533","LU0234572021.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU1868836914.USD","LU1974910355.USD","LU1061106388.HKD","LU2237443895.HKD","LU2357305700.SGD","LU1983299246.USD","LU0417517546.SGD","SG9999015986.USD","IE00BK4W5L77.USD","LU0203201768.USD","LU1057294990.SGD","LU2360106947.USD","LU2471134879.HKD","LU0109391861.USD","IE00B1BXHZ80.USD","LU1868836757.USD","LU1917777945.USD","BK4516","IE00BLSP4239.USD","LU2264538146.SGD","BK4599","LU1551013425.SGD","BK4581","SGXZ51526630.SGD","SGXZ99366536.SGD","LU1127390331.HKD","PFE","LU0238689110.USD","BK4007","LU0321505439.SGD","LU1988902786.USD","SG9999013999.USD","LU0943347566.SGD","SG9999017495.SGD","LU2750360641.GBP","LU1894683264.USD"],"gpt_icon":1},{"id":"2528886930","title":"輝瑞4月17日成交額為12.06億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528886930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528886930?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 10:20","pubTimestamp":1744942854,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，辉瑞成交额为12.06亿美元，成交额较昨日增加44.24%，当日成交量为5407.37万股。辉瑞于2025年4月17日涨0.45%，报22.14美元，该股过去5个交易日涨2.55%，年初至今跌15.16%，过去60日跌13.47%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|12.06亿|44.24%|5407.37万|#|2025-04-16|8.36亿|-28.41%|3764.12万|#|2025-04-15|11.68亿|-14.48%|5181.47万|#|2025-04-14|13.66亿|14.34%|6190.09万|#|2025-04-11|11.95亿|-24.16%|5507.81万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102055a6beb6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102055a6beb6ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","SG9999003800.SGD","LU1066053197.SGD","PFE","LU1023059063.AUD","SG9999002232.USD","BK4568","IE00B19Z3B42.SGD","LU0234572021.USD","BK4581","LU0321505868.SGD","LU1066051498.USD","BK4585","LU0868494617.USD","LU1883839398.USD","BK4588","IE00BLSP4239.USD","BK4599","LU0122379950.USD","LU0225284248.USD","SG9999001176.USD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4534","SGXZ57979304.SGD","SG9999002224.SGD","LU0306807586.USD","BK4533","LU0289739699.SGD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","IE0002270589.USD","LU1894683264.USD","BK4007","LU1894683348.USD","LU0058720904.USD","BK4550","SG9999013999.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2528882380","title":"諾和諾德4月17日成交額為18.73億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528882380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528882380?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 10:14","pubTimestamp":1744942451,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，诺和诺德成交额为18.73亿美元，成交额较昨日增加368.67%，当日成交量为3222.06万股。诺和诺德于2025年4月17日跌7.63%，报58.08美元，该股过去5个交易日跌5.11%，年初至今跌31.67%，过去60日跌27.05%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418101413a6beb4d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418101413a6beb4d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2528048847","title":"【減肥藥概念盤初活躍 金凱生科漲超10%】減肥藥概念盤初活躍，金凱生科漲超10%，昊帆生物、華東醫藥、翰宇藥業、百花醫藥、一品紅、常山藥業等跟漲。消息面上，禮來口服減肥藥Orforglipron三期臨牀數據亮眼，股價漲逾14%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528048847","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528048847?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 09:26","pubTimestamp":1744939617,"startTime":"0","endTime":"0","summary":"减肥药概念盘初活跃，金凯生科涨超10%，昊帆生物、华东医药、翰宇药业、百花医药、一品红、常山药业等跟涨。消息面上，礼来口服减肥药Orforglipron三期临床数据亮眼，股价涨逾14%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"17136e9096e01d550821b3b9313a36c7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18092649644252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0203201768.USD","301393","LU0456855351.SGD","LU0820561818.USD","LU0385154629.USD","LU0708995401.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","300255","BK4599","LU1069344957.HKD","LU1983299246.USD","LU2237443895.HKD","LU2112291526.USD","BK0028","LU1868836914.USD","LU2265009873.SGD","GB00BDT5M118.USD","LU1093756168.USD","LU2237438978.USD","LU0122379950.USD","SG9999017495.SGD","IE00B2B36J28.USD","LU1804176565.USD","LU2361045086.USD","LU2357305700.SGD","BK0070","300199","LU0238689110.USD","LU0256863902.USD","SGXZ99366536.SGD","300723","IE00BJT1NW94.SGD","LU2237443465.HKD","LU2461242641.AUD","LU1057294990.SGD","000963","LU0256863811.USD","SG9999014914.USD","LU1551013425.SGD","LU2324357040.USD","LU2328871848.SGD","IE0004445239.USD","SGXZ57979304.SGD","LU2491050154.USD","301509","LU0097036916.USD","LU2023250504.SGD","600721"],"gpt_icon":0},{"id":"2528582745","title":"諾和諾德盤初跌8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528582745","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528582745?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 21:47","pubTimestamp":1744897672,"startTime":"0","endTime":"0","summary":"诺和诺德盘初跌8%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504173380246517.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504173380246517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756168.USD","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":0},{"id":"2528436147","title":"碩迪生物盤中異動 早盤急速上漲19.86%報22.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528436147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528436147?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 21:31","pubTimestamp":1744896692,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时31分，硕迪生物股票出现波动，股价急速拉升19.86%。截至发稿，该股报22.21美元/股，成交量18.6616万股，换手率0.33%，振幅5.82%。硕迪生物股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为349.36%、130.22%、44.12%，振幅较大的相关个股有Channel Therapeutics Corporation、Celularity Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为17.53%、12.20%、9.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213132a6be09e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213132a6be09e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"1122028669","title":"盤前 | 禮來漲超11%，聯合健康重挫19%；霸王茶姬今日上市，IPO定價28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122028669","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122028669?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 19:55","pubTimestamp":1744890900,"startTime":"0","endTime":"0","summary":"台积电预计，第二季度销售额284亿美元至292亿美元，市场预估271.6亿美元。第二季度营业利润率将达47%至49%，上一季度为48.5%。预计第二季度毛利率将达到57%至59%，上一季度为58.8%。这将进一步推动礼来减少2型糖尿病等慢性病的使命，预计到2050年，预计2型糖尿病将影响大约7.6亿成年人。联合健康盘前跌超19%，下调全年盈利指引联合健康一季度营收1095.75亿美元，预期1115.1亿美元。纳斯达克官网显示，霸王茶姬于2025 年 4 月 17 日晚正式在纳斯达克上市。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".DJI","IE00B19Z9505.USD","NVDA","IE00B894F039.SGD","UNH","LU1057294990.SGD",".SPX","BK4599","LU0053666078.USD","IE0004445239.USD","IE00B2B36J28.USD","LU0052756011.USD","CHA","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00BJJMRY28.SGD","BK4585","BK4532","IE0009355771.USD","IE00BN29S564.USD","BABA",".IXIC","LLY","LU0456855351.SGD","LU0385154629.USD"],"gpt_icon":1},{"id":"2528718414","title":"蒙特利爾銀行：將輝瑞（PFE.N）目標價從36美元下調至30美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528718414","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528718414?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 19:23","pubTimestamp":1744889039,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","BMO","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","LU0868494617.USD","BK4533","BK4207","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2528379793","title":"禮來(LLY.N)盤前大漲13%，此前其發佈了減肥藥研究數據。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528379793","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528379793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 18:52","pubTimestamp":1744887142,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"17136e9096e01d550821b3b9313a36c7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0203202063.USD","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU2552382215.SGD","IE00BJT1NW94.SGD","LU2237438978.USD","LU2264538146.SGD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU2552382132.HKD","LU0122379950.USD","LU0203201768.USD","LU2237443382.USD","LU1868836591.USD","LU1093756325.SGD","BK4599","LU0097036916.USD","LU0471298694.HKD","LU0820561818.USD","LU0820561909.HKD","LU0689472784.USD","LU1868836914.USD","LU1057294990.SGD","LLY","LU0320765059.SGD","LU0882574139.USD","LU2237443549.SGD","LU0466842654.USD","LU1989771016.USD","LU1868837300.USD","LU0943347566.SGD","LU0708995401.HKD","LU1868836757.USD","LU1868837136.USD","SGXZ57979304.SGD","LU2237443622.USD","LU1974910355.USD","LU2552382058.USD","SG9999014880.SGD","LU2237443978.SGD","IE0004445239.USD","LU2023250504.SGD","SG9999015986.USD","BK4533","LU0061475181.USD","LU0106261372.USD","LU0289739699.SGD","SG9999018857.SGD","BK4534","LU0823416689.USD"],"gpt_icon":0},{"id":"2528873881","title":"輝瑞4月16日成交額為8.36億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528873881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528873881?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 10:16","pubTimestamp":1744856184,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日，辉瑞成交额为8.36亿美元，成交额较昨日减少28.41%，当日成交量为3764.12万股。辉瑞于2025年4月16日跌1.78%，报22.04美元，该股过去5个交易日跌2.0%，年初至今跌15.55%，过去60日跌15.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-16|8.36亿|-28.41%|3764.12万|#|2025-04-15|11.68亿|-14.48%|5181.47万|#|2025-04-14|13.66亿|14.34%|6190.09万|#|2025-04-11|11.95亿|-24.16%|5507.81万|#|2025-04-10|15.75亿|-24.50%|7296.07万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101627a45bd947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101627a45bd947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU0306807586.USD","PFE","LU1066053197.SGD","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","BK4599","SG9999002232.USD","LU0321505439.SGD","BK4534","LU0170899867.USD","LU0321505868.SGD","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","IE0002270589.USD","SG9999001176.USD","LU0225284248.USD","BK4592","BK4007","BK4533","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999011175.SGD","LU1057294990.SGD","LU0868494617.USD","BK4588","SG9999003800.SGD","BK4585","IE00BLSP4239.USD","LU0122379950.USD","LU1894683348.USD","BK4581","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","LU0058720904.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999001176.SGD","LU0985481810.HKD","BK4550","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2528738993","title":"諾和諾德4月16日成交額為4.00億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528738993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528738993?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 10:10","pubTimestamp":1744855821,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日，诺和诺德成交额为4.00亿美元，成交额较昨日增加3.93%，当日成交量为630.26万股。诺和诺德于2025年4月16日跌2.5%，报62.88美元，该股过去5个交易日跌3.4%，年初至今跌26.03%，过去60日跌21.47%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101030a45bd786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101030a45bd786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0154236417.USD","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","NVO","BK4585","BK4532","BK4588"],"gpt_icon":1},{"id":"2528787721","title":"禮來4月16日成交額為24.37億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528787721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528787721?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 09:50","pubTimestamp":1744854627,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日，礼来成交额为24.37亿美元，成交额较昨日增加30.87%，当日成交量为330.26万股。礼来于2025年4月16日跌2.94%，报734.9美元，该股过去5个交易日跌2.5%，年初至今跌4.64%，过去60日跌0.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-16|24.37亿|30.87%|330.26万|#|2025-04-15|18.62亿|-28.31%|245.81万|#|2025-04-14|25.98亿|-0.95%|346.12万|#|2025-04-11|26.23亿|-12.56%|360.34万|#|2025-04-10|29.99亿|-37.21%|418.27万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417095029a6bd45ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417095029a6bd45ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0096364046.USD","LU0203201768.USD","BK4585","LU1064131342.USD","LU1093756325.SGD","LU2023250504.SGD","LU2357305700.SGD","LU2491050071.SGD","LU0256863902.USD","SG9999014906.USD","LU0689472784.USD","LU2461242641.AUD","LU1291159041.SGD","LU0943347566.SGD","LU1814569148.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0106261372.USD","LU1023059063.AUD","BK4533","LU1232071149.USD","LLY","SGXZ57979304.SGD","LU2237443382.USD","LU2211815571.USD","GB00BDT5M118.USD","LU1623119135.USD","LU0471298694.HKD","LU1720051017.SGD","SG9999001176.USD","LU0079474960.USD","LU0198837287.USD","LU1548497426.USD","BK4599","LU2237443895.HKD","LU2089984988.USD","SGXZ51526630.SGD","SG9999014914.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1712237335.SGD","SG9999014898.SGD","LU2552382058.USD","IE00BK4W5L77.USD","LU2360106947.USD","LU2491049909.HKD","LU1974910355.USD","LU0820561818.USD","LU2471134879.HKD","LU2750360997.AUD"],"gpt_icon":1},{"id":"2528080752","title":"輝瑞：CDC建議將呼吸道合胞病毒疫苗擴大到年輕人。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528080752","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528080752?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 04:33","pubTimestamp":1744835634,"startTime":"0","endTime":"0","summary":"辉瑞：CDC建议将呼吸道合胞病毒疫苗扩大到年轻人。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/17043349604117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0306806265.USD","LU1023059063.AUD","LU0985481810.HKD","CDC","LU0289739699.SGD","LU1883839398.USD","SG9999003800.SGD","LU1057294990.SGD","BK4533","PFE","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0122379950.USD","BK4581","BK4599","BK4568","SG9999002224.SGD","LU0456855351.SGD","LU0225771236.USD","LU0058720904.USD","LU0170899867.USD","IE00BLSP4452.SGD","SG9999001176.SGD","BK4550","BK4534","LU0321505439.SGD","LU0234572021.USD","LU0306807586.USD","SG9999013999.USD","LU1066053197.SGD","LU0868494617.USD","BK4007","LU1066051498.USD","159646","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4588","LU0321505868.SGD","IE0002270589.USD","LU1894683348.USD","SG9999011175.SGD","BK4592","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4585","LU0225284248.USD"],"gpt_icon":0},{"id":"2528222859","title":"【歐股“十一羅漢”收盤播報｜阿斯麥收跌約5.2%，諾和諾德跌超1%】 週三，阿斯麥控股荷蘭阿姆斯特丹股價收跌5.19%，報574.00歐元。諾和諾德哥本哈根股價收跌1.03%，報421.30。賽諾菲跌1.34%，LVMH集團、歐萊雅、羅氏製藥、阿斯利康、德國思愛普Sap、葛蘭素史克跌0.71%-0.04%，諾華和雀巢分別漲0.29%和0.49%。此外，半導體概念股普遍收跌，除阿斯麥控股之外，BE半導體實業和ASM國際至多跌3.2%，Soitec、德國愛思強、意法半導體跌1.85%-1.31%，英飛凌也跌0.96%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528222859","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528222859?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 00:37","pubTimestamp":1744821436,"startTime":"0","endTime":"0","summary":"周三，阿斯麦控股荷兰阿姆斯特丹股价收跌5.19%，报574.00欧元。诺和诺德哥本哈根股价收跌1.03%，报421.30。赛诺菲跌1.34%，LVMH集团、欧莱雅、罗氏制药、阿斯利康、德国思爱普Sap、葛兰素史克跌0.71%-0.04%，诺华和雀巢分别涨0.29%和0.49%。此外，半导体概念股普遍收跌，除阿斯麦控股之外，BE半导体实业和ASM国际至多跌3.2%，Soitec、德国爱思强、意法半导体跌1.85%-1.31%，英飞凌也跌0.96%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/17003749603707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4532","BK4543","ASM","GSK","LU1734074674.USD","BK1574","BK4554","IE00B4R5TH58.HKD","LU2506951792.HKD","STM","LU2249611893.SGD","BK4568","LU0823434740.USD","NVS","LU0345774631.USD","IE00BD6J9T35.USD","LU0097036916.USD","BE","01477","IE0004445239.USD","LU0320765489.SGD","IE0009355771.USD","BK4541","GSK.UK","LU0889565916.HKD","LU2063271972.USD","BK4585","LU0211331839.USD","LU1642822529.SGD","AZN","IE00BZ1G4Q59.USD","LU0823414478.USD","LU0208291251.USD","LU0320765992.SGD","BK4599","BK4212","NSRGY","BK4578","LU0823434583.USD","BK4588","ASML","BK4604","BK4141","LU1093756168.USD","BK1191","BK4188","NVO","03165","LRLCY","159582"],"gpt_icon":0},{"id":"2527365244","title":"碩迪生物盤中異動 股價大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527365244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527365244?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 22:17","pubTimestamp":1744813065,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时17分，硕迪生物股票出现波动，股价急速跳水5.03%。截至发稿，该股报17.95美元/股，成交量10.3313万股，换手率0.18%，振幅4.36%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416221746a6bcadb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416221746a6bcadb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2527245520","title":"因受試者出現肝損傷項目終止 輝瑞減肥藥研發再遇挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2527245520","media":"新京报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527245520?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 21:33","pubTimestamp":1744810415,"startTime":"0","endTime":"0","summary":"在当下正热的胰高糖素样肽-1受体激动剂（GLP-1）药物领域，美国制药巨头辉瑞似乎缺少了一些运气。当地时间4月14日，辉瑞宣布终止口服GLP-1受体激动剂Danuglipron的研发，该药物此前被开发用于慢性体重管理。辉瑞此前已终止口服GLP-1候选药物Lotiglipon（每日一次）的开发，目前仅剩一款口服GIPR拮抗剂处于二期临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504163378947287.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504163378947287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1057294990.SGD","SG9999003800.SGD","LU1066053197.SGD","PFE","LU1023059063.AUD","SG9999002232.USD","BK4568","IE00B19Z3B42.SGD","LU0234572021.USD","BK4581","LU0321505868.SGD","LU1066051498.USD","BK4585","LU0868494617.USD","LU1883839398.USD","BK4588","IE00BLSP4239.USD","BK4599","LU0122379950.USD","LU0225284248.USD","SG9999001176.USD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4534","SGXZ57979304.SGD","SG9999002224.SGD","LU0306807586.USD","BK4533","LU0289739699.SGD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","IE0002270589.USD","LU1894683264.USD","BK4007","LU1894683348.USD","LU0058720904.USD","BK4550","SG9999013999.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2527532245","title":"禮來(LLY.US)米吉珠單抗注射液新適應症上市申請獲CDE受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2527532245","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527532245?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 21:13","pubTimestamp":1744809180,"startTime":"0","endTime":"0","summary":"今日，中国国家药监局药品审评中心官网最新公示，礼来公司申报的米吉珠单抗注射液以及其皮下注射剂型的新适应症上市申请获得受理。截图来源：CDE官网米吉珠单抗是一款人源化IgG4单克隆抗体，可与IL-23的p19亚基结合，阻断IL-23介导的炎症反应。根据礼来此前新闻稿，这是首个用于治疗这一患者群体的IL-23p19拮抗剂。2025年1月，米吉珠单抗再次获FDA批准，用于治疗成人中度至重度活动性克罗恩病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-16/doc-inetkpat4324726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0203201768.USD","LU0203202063.USD","LU2106854487.HKD","LU2552382215.SGD","LU1267930730.SGD","LU0708995401.HKD","SG9999015986.USD","LU1720051108.HKD","BK4599","LU2237443895.HKD","LU0109391861.USD","LU2750360997.AUD","LU2265009873.SGD","LU0096364046.USD","GB00BDT5M118.USD","LU1093756168.USD","SGXZ31699556.SGD","LU0640476718.USD","LU2089984988.USD","BK4017","LU2237438978.USD","LU0061475181.USD","LU1366192091.USD","LU0354030438.USD","LU2361045086.USD","LU2750360641.GBP","LU2357305700.SGD","BK4534","LU0238689110.USD","SGXZ99366536.SGD","LU0256863902.USD","SGXZ51526630.SGD","LU1720051017.SGD","LLY","LU0320765059.SGD","LU2491050071.SGD","LU2461242641.AUD","CDEDC","SG9999015952.SGD","CDE","LU2471134796.USD","SG9999018865.SGD","LU2468319806.SGD","LU0471298777.SGD","LU0114720955.EUR","LU0354030511.USD","BK4533","LU2491050154.USD","LU1280957306.USD","SG9999001176.USD","LU2491049909.HKD"],"gpt_icon":1},{"id":"2527297956","title":"輝瑞、禮來新適應症在華報產！康弘Trop2-ADC嶄露頭角","url":"https://stock-news.laohu8.com/highlight/detail?id=2527297956","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527297956?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 19:06","pubTimestamp":1744801572,"startTime":"0","endTime":"0","summary":"辉瑞 PARP 抑制剂新适应症在华申报上市今日，CDE官网显示，辉瑞制药的甲苯磺酸他拉唑帕利胶囊新适应症上市申请获受理。根据注册分类以及临床试验进展推测，此次申报的适应症为胚系 BRCA突变的HER2阴性乳腺癌。根据公开资料推测，本次该药申报上市的适应症为治疗中重度活动性溃疡性结肠炎成人患者。根据礼来此前新闻稿，这是首个用于治疗这一患者群体的IL-23p19拮抗剂。此外，礼来已于2024年10月公布了多年期的Ⅲ期试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416191552a6bc81e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416191552a6bc81e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999017495.SGD","LU2750360641.GBP","SG9999014898.SGD","LU0868494617.USD","LU1894683264.USD","ADC","LU1868837300.USD","LU1232071149.USD","SG9999018857.SGD","LU0823416689.USD","LU1057294990.SGD","LU0234572021.USD","SGXZ99366536.SGD","LU2468319806.SGD","LU0882574139.USD","PFE","IE00BJT1NW94.SGD","LU0058720904.USD","LU0256863902.USD","LU2361044865.SGD","LU0456855351.SGD","LU2361045086.USD","BK4599","LU1917777945.USD","LU0985481810.HKD","LU2552382132.HKD","LU0354030511.USD","LU2491049909.HKD","SG9999015986.USD","LU1868836757.USD","SG9999014906.USD","LU0672654240.SGD","LU0122379950.USD","LU2237443382.USD","LU2211815571.USD","IE0002270589.USD","LU0689472784.USD","LU0114720955.EUR","IE00BBT3K403.USD","LU2471134523.USD","LU1974910355.USD","LU0943347566.SGD","LU0385154629.USD","LLY","LU0417517546.SGD","LU1868837136.USD","LU1548497426.USD","LU1720051017.SGD","LU1894683348.USD","LU2237443549.SGD"],"gpt_icon":1},{"id":"2527291392","title":"文件顯示，沃爾瑪與欽奈辦事處達成交易，提升在印度的科技影響力","url":"https://stock-news.laohu8.com/highlight/detail?id=2527291392","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527291392?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 18:51","pubTimestamp":1744800703,"startTime":"0","endTime":"0","summary":"路透班加罗尔4月16日 - 沃尔玛WMT.N在印度南部城市钦奈签署了第二个办公空间的协议，钦奈在作为制造业中心闻名多年后，正迅速崛起为一个重要的技术中心。据路透周三看到的一份文件显示，沃尔玛已经租下了超过465,000平方英尺的面积，最初租期为5年，从今年11月开始。尽管沃尔玛尚未在印度经营超市，但它在钦奈和班加罗尔等城市设有技术办事处。沃尔玛没有立即回应路透的置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4T3QU0T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800965.SGD","LU1481599808.USD","LU0175139822.USD","LU0496365809.HKD","LU2133065610.SGD","LU1267930227.SGD","LU2360032135.SGD","LU1153584641.USD","LU0499090636.EUR","LU0211327993.USD","BK4599","03165","LU0203345920.USD","LU0077335932.USD","LU2112291526.USD","LU1066053197.SGD","LU1066051811.HKD","LU2264538146.SGD","IE0002141913.USD","LU2097829019.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","LU1035773651.USD","LU1366192091.USD","LU0868494617.USD","IE0034235188.USD","IE00B7SZLL34.SGD","LU1064131342.USD","LU0211328371.USD","LU0256863902.USD","LU1119994496.HKD","IE0004445015.USD","LU0170899867.USD","LU1814569148.SGD","LU2108987350.USD","LU2471134879.HKD","LU0211326755.USD","LU1057294990.SGD","LU0545039389.USD","AZN.UK","LU0882574055.USD","LU0784384876.USD","IE00B4R5TH58.HKD","LU2430703251.USD","LU1894683348.USD","WMT","UPS","LU1066051225.USD","IE000M9KFDE8.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":118,"code":"91000000","status":"200"}]}}